发明名称 Therapeutic substituted indazole derivatives
摘要 The invention provides a compound of Formula I Formula I wherein R<SUP>1 </SUP>is aryl or heteroaryl each of which is optionally substituted with one or more of the following R<SUP>3</SUP>, -OR<SUP>3</SUP>, -OCOR<SUP>3</SUP>, -COOR<SUP>3</SUP>, -COR<SUP>3</SUP>, -CONR<SUP>3</SUP>R<SUP>4</SUP>, -NHCOR<SUP>3</SUP>, -NR<SUP>3</SUP>R<SUP>4</SUP>, -NHSO<SUB>2</SUB>R<SUP>3</SUP>, -S<SUB>2</SUB>R<SUP>3</SUP>, -SO<SUB>2</SUB>NR<SUP>3</SUP>R<SUP>4</SUP>, -SR<SUP>3</SUP>, CN, halogeno or NO<SUB>2</SUB>; R<SUP>2 </SUP>is NO<SUB>2</SUB>, NH<SUB>2</SUB>, -NR<SUP>5</SUP>R<SUP>6 </SUP>or -NR<SUP>6</SUP>R<SUP>7</SUP>; as a free base or a pharmaceutically acceptable salt, solvate or solvate of salt thereof, a process for their preparation, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
申请公布号 US2005113370(A1) 申请公布日期 2005.05.26
申请号 US20040504411 申请日期 2004.08.12
申请人 MALMSTROM JONAS;SWAHN BRITT-MARIE 发明人 MALMSTROM JONAS;SWAHN BRITT-MARIE
分类号 A61K31/416;A61K31/4439;A61K31/454;A61K31/496;A61K31/5377;A61K31/541;A61P1/02;A61P7/10;A61P9/00;A61P19/02;A61P21/00;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P29/00;A61P29/02;A61P31/18;A61P35/00;A61P43/00;C07D231/56;C07D401/10;C07D401/12;C07D403/10;C07D403/12;C07D405/04;C07D405/12;(IPC1-7):A61K31/541;A61K31/537;C07D417/02;C07D413/02 主分类号 A61K31/416
代理机构 代理人
主权项
地址